TScan Therapeutics announces reorganization to focus on solid-tumor cell therapy
TScan Therapeutics says it will reorganize to focus on in vivo cell therapy for solid tumors.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.